Cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult patients (aged >= 18 years); 2) Patients who underwent laparoscopic radical hysterectomy for cervical cancer (regardless of whether adjuvant therapy was administered postoperatively and the specific adjuvant treatment regimen); 3) Patients with postoperative follow-up duration ranging from 3 months to 10 years; 4) No evidence of tumor recurrence at the time of inclusion; 5) Patients with clear consciousness and ability to complete questionnaires and urodynamic testing; 6) Willingness to participate in the study and provision of signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Presence of chronic conditions affecting urinary function, such as diabetes or neurological disorders (e.g., Parkinson’s disease, multiple system atrophy, multiple sclerosis, spinal cord lesions). 2) History of preoperative urinary or bowel symptoms, pelvic organ prolapse surgery, anti-incontinence surgery, or bladder injury/surgery. 3) History of vesicoureteral reflux, hydronephrosis, recurrent urinary tract infections, or urethral stricture. 4) Perioperative complications, including bleeding, injury, reoperation, or postoperative vesicovaginal fistula.5) Contraindications to urodynamic testing. 6) Use of medications affecting voiding within the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevalence of neurogenic bladder; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Score; | — |
Countries
China
Contacts
Shanghai First Maternity and Infant Hospital